Scalper1 News
Big pharma AstraZeneca (AZN) and big biotech Amgen (AMGN) were both down nearly 3% in heavy trading Tuesday, after Amgen said late Friday that it was withdrawing from their partnership to develop an immunology drug after some patients killed themselves. Amgen said that “suicidal ideation and behavior” in some patients in the clinical trials of brodalumab, which is being tested for psoriasis, psoriatic arthritis and axial spondyloarthritis, would Scalper1 News
Scalper1 News